神经症和抑郁障碍患者的述情障碍及相关因素研究

目的探讨神经症和抑郁障碍患者的述情障碍及影响因素。方法对57例神经症和抑郁障碍患者运用多伦多述情障碍量表(TAS)进行评定，并与常模进行比较。结果神经症和抑郁障碍患者存在明显的述情障碍，TAS总分及各因子分明显高于常模，男女之间无显著性差异，多元回归分析进入方程的是SCL-90躯体化因子和焦虑因子。结论正确评定神经症和郁郁障碍患者的述情障碍及影响因素，具有重要的临床现实意义，对采用适当的心理治疗提供依据。

Alexithymia and its affective factors in patients with neuroses and depressive disorder

Objective: To study the alexithymia and its affective factors in patients with neuroses and depressive disorder. Methods: Toronto Alexithymia Scale (TAS) was applied with 60 cases diagnosed as neuroses and depressive disorder by comparing with normal. Results: Significant higher total TAS and four factors scores in neuroses and depressive disorder indicated marked Alexithymia in neuroses, and there was no significant difference between male and female. The severity of SCL-90 somatization and anxiety factors were the most two important influencing factors to the TAS. Conclusion: It is very important for chosing the more proper psychological methods in the treatment of neuroses and depressive disorder to evaluate the alexithymia of neuroses patients correctly.